IWM vs MRSN
iShares Russell 2000 ETF (IWM) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
iShares Russell 2000 ETF (IWM) common stock listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
IWM does not have a complete income-statement cache yet.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
IWM currently screens at market cap $0. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the IWM and MRSN stock pages for the full models.
Not investment advice.